Associations between hsa-MIR-603 polymorphism, lifestyle-related factors and colorectal cancer risk

Cancer Biomarkers

Volumn 14, Issue 4, 2014, Pages 225-231

  Wang, Fen Juan ^a   Ding, Ye ^b   Mao, Ying Ying ^b   Jing, Fang Yuan ^b   Zhang, Zhen Yu ^b   Jiang, Long Fang ^a   Guo, Jian Feng ^a   Sun, Xiang Jue ^a   Jin, Ming Juan ^b   Chen, Kun ^b  

^a Center for Disease Control and Prevention of Xiaoshan ^*  (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

colorectal cancer; hsa MIR 603; polymorphism; susceptibility

Indexed keywords

MICRORNA; MICRORNA 603; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER RISK; CASE CONTROL STUDY; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; CHINA; COLORECTAL NEOPLASMS; GENETICS; MIDDLE AGED;

CASE-CONTROL STUDIES; CHINA; COLORECTAL NEOPLASMS; FEMALE; GENOTYPE; HUMANS; LIFE STYLE; MALE; MICRORNAS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84921644448     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-140395     Document Type: Article

References (37)

1. A. Shin, Colorectal cancer mortality in Hong Kong of China, Japan, South Korea, and Singapore, World Journal of Gastroenterology 19 (2013), 979.
2. T. Lei, W. Chen, S. Zhang, T. Lei, Q. Ying, Z. He and X. Wang, Prevalence trend of colorectal cancer in 10 cities and counties in China from 1988 to 2002, Zhonghua zhong liu za zhi [Chinese Journal of Oncology] 31 (2009), 428.
3. D.S. Wan, [Epidemiological trend and control strategy of colorectal cancer in China], Zhonghua Zhong Liu Za Zhi 33 (2011), 481-3.
4. J. Prescott, U. Jariwala, L. Jia, J.P. Cogan, A. Barski, S. Pregizer, H.C. Shen, A. Arasheben, J.J. Neilson and B. Frenkel, Androgen receptor-mediated repression of novel target genes, The Prostate 67 (2007), 1371-1383.
5. D.P. Bartel, MicroRNAs: genomics, biogenesis, mechanism, and function, Cell 116 (2004), 281-97.
6. R. Duan, C. Pak and P. Jin, Single nucleotide polymorphism associated with mature miR-125a alters the processing of primiRNA, Hum Mol Genet 16 (2007), 1124-31.
7. A. Lujambio, S. Ropero, E. Ballestar, M.F. Fraga, C. Cerrato, F. Setien, S. Casado, A. Suarez-Gauthier, M. Sanchez- Cespedes, A. Git, I. Spiteri, P.P. Das, C. Caldas, E. Miska and M. Esteller, Genetic unmasking of an epigenetically silenced microRNA in human cancer cells, Cancer Res 67 (2007), 1424-9.
8. B.M. Ryan, A.C. McClary, N. Valeri, D. Robinson, A. Paone, E.D. Bowman, A.I. Robles, C. Croce and C.C. Harris, rs4919510 in hsa-mir-608 is associated with outcome but not risk of colorectal cancer, PLoS One 7 (2012), e36306.
9. E. Barbarotto, T.D. Schmittgen and G.A. Calin, MicroRNAs and cancer: profile, profile, profile, Int J Cancer 122 (2008), 969-77.
10. J. Lu, G. Getz, E.A. Miska, E. Alvarez-Saavedra, J. Lamb, D. Peck, A. Sweet-Cordero, B.L. Ebert, R.H. Mak, A.A. Ferrando, J.R. Downing, T. Jacks, H.R. Horvitz and T.R. Golub, MicroRNA expression profiles classify human cancers, Nature 435 (2005), 834-8.
11. R. Garzon and G. Marcucci, Potential of microRNAs for cancer diagnostics, prognostication and therapy, Current Opinion in Oncology 24 (2012), 655-659.
12. K.A. Cissell, Y. Rahimi, S. Shrestha, E.A. Hunt and S.K. Deo, Bioluminescence-based detection of microRNA, miR21 in breast cancer cells, Anal Chem 80 (2008), 2319-25.
13. N. Yamamichi, R. Shimomura, K. Inada, K. Sakurai, T. Haraguchi, Y. Ozaki, S. Fujita, T. Mizutani, C. Furukawa, M. Fujishiro, M. Ichinose, K. Shiogama, Y. Tsutsumi, M. Omata and H. Iba, Locked nucleic acid in situ hybridization analysis of miR-21 expression during colorectal cancer development, Clin Cancer Res 15 (2009), 4009-16.
14. W. Gao, Y. Yu, H. Cao, H. Shen, X. Li, S. Pan and Y. Shu, Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis, Biomed Pharmacother 64 (2010), 399-408.
15. Q. Ma, Q. Jiang, Q. Pu, X. Zhang,W. Yang, Y. Wang, S. Ye, S. Wu, G. Zhong and J. Ren, MicroRNA-143 inhibits migration and invasion of human non-small-cell lung cancer and its relative mechanism, International Journal of Biological Sciences 9 (2013), 680.
16. H. Guo, Y. Chen, X. Hu, G. Qian, S. Ge and J. Zhang, The regulation of toll-like receptor 2 by miR-143 suppresses the invasion and migration of a subset of human colorectal carcinoma cells, Molecular Cancer 12 (2013), 77.
17. H. Yoshino, N. Seki, T. Itesako, T. Chiyomaru, M. Nakagawa and H. Enokida, Aberrant expression of microRNAs in bladder cancer, Nature Reviews Urology (2013).
18. B.M. Ryan, A.I. Robles and C.C. Harris, Genetic variation in microRNA networks: The implications for cancer research, Nat Rev Cancer 10 (2010), 389-402.
19. D.W. Salzman and J.B. Weidhaas, SNPing cancer in the bud: microRNA and microRNA-target site polymorphisms as diagnostic and prognostic biomarkers in cancer, Pharmacol Ther 137 (2013), 55-63.
20. Y. Dong,W.K.K. Wu, C.W. Wu, J.J.Y. Sung, J. Yu and S.S.M. Ng, MicroRNA dysregulation in colorectal cancer: a clinical perspective, British Journal of Cancer 104 (2011), 893-898.
21. L. Zhu, H. Chu, D. Gu, L. Ma, D. Shi, D. Zhong, N. Tong, Z. Zhang and M. Wang, A functional polymorphism in miRNA- 196a2 is associated with colorectal cancer risk in a Chinese population, DNA Cell Biol 31 (2012), 350-4.
22. M.A. Nalesnik, G. Tseng, Y. Ding, G.S. Xiang, Z.L. Zheng, Y. Yu, J.W. Marsh, G.K. Michalopoulos and J.H. Luo, Gene deletions and amplifications in human hepatocellular carcinomas: correlation with hepatocyte growth regulation, Am J Pathol 180 (2012), 1495-508.
23. W. Langer, F. Sohler, G. Leder, G. Beckmann, H. Seidel, J. Grone, M. Hummel and A. Sommer, Exon array analysis using re-defined probe sets results in reliable identification of alternatively spliced genes in non-small cell lung cancer, BMC Genomics 11 (2010), 676.
24. J. Yu, A. Li, S.M. Hong, R.H. Hruban and M. Goggins, MicroRNA Alterations of Pancreatic Intraepithelial Neoplasias, Clinical Cancer Research 18 (2011), 981-992.
25. D. D'Angelo, D. Palmieri, P. Mussnich, M. Roche, A. Wierinckx, G. Raverot, M. Fedele, C.M. Croce, J. Trouillas and A. Fusco, Altered MicroRNA Expression Profile in Human Pituitary GH Adenomas: Down-Regulation of miRNA Targeting HMGA1, HMGA2, and E2F1, Journal of Clinical Endocrinology & Metabolism 97 (2012), E1128-E1138.
26. E.K. Ng,W.W. Chong, H. Jin, E.K. Lam, V.Y. Shin, J. Yu, T.C. Poon, S.S. Ng and J.J. Sung, Differential expression of microRNAs in plasma of patients with colorectal cancer: A potential marker for colorectal cancer screening, Gut 58 (2009), 1375-81.
27. Z. Huang, D. Huang, S. Ni, Z. Peng, W. Sheng and X. Du, Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer, Int J Cancer 127 (2010), 118-26.
28. J. Wang, Q. Wang, H. Liu, N. Shao, B. Tan, G. Zhang, K. Wang, Y. Jia, W. Ma, N. Wang and Y. Cheng, The association of miR-146a rs2910164 and miR-196a2 rs11614913 polymorphisms with cancer risk: a meta-analysis of 32 studies, Mutagenesis 27 (2012), 779-88.
29. Z. Mw, J. Mj, Y. Yx, Z. Sc, L. B, J. X, P. Yf, L. Ql, M. Xy and C. K, Associations of lifestyle-related factors, hsa-miR-149 and hsa-miR-605 gene polymorphisms with gastrointestinal cancer risk, Molecular Carcinogenesis 51 (2012), E21-E31.
30. Z. Wu, S. Zheng, Z. Li, J. Tan and Q. Yu, E2F1 suppresses Wnt/β-catenin activity through transactivation of β-catenin interacting protein ICAT, Oncogene 30 (2011), 3979-3984.
31. S. Mookherjee, M. Sinha, S. Mukhopadhyay, N.P. Bhattacharyya and P. Mohanty, MicroRNA Interaction network in human: Implications of clustered microRNA in biological pathways and genetic diseases, arXiv preprint arXiv:0901.4211 (2009).
32. N. Kontou, T. Psaltopoulou, N. Soupos, E. Polychronopoulos, D. Xinopoulos, A. Linos and D. Panagiotakos, Alcohol Consumption and Colorectal Cancer in a Mediterranean Population, Diseases of the Colon & Rectum 55 (2012), 703-710.
33. S. Nechuta, X.O. Shu, H.L. Li, G. Yang, B.T. Ji, Y.B. Xiang, H. Cai, W.H. Chow, Y.T. Gao and W. Zheng, Prospective cohort study of tea consumption and risk of digestive system cancers: results from the Shanghai Women's Health Study, American Journal of Clinical Nutrition 96 (2012), 1056-1063.
34. H. Nisa, S. Kono, G. Yin, K. Toyomura, J. Nagano, R. Mibu, M. Tanaka, Y. Kakeji, Y. Maehara, T. Okamura, K. Ikejiri, K. Futami, T. Maekawa, Y. Yasunami, K. Takenaka, H. Ichimiya and R. Terasaka, Cigarette smoking, genetic polymorphisms and colorectal cancer risk: the Fukuoka Colorectal Cancer Study, BMC Cancer 10 (2010), 274.
35. J.Y. Park, P.N. Mitrou, C.C. Dahm, R.N. Luben, N.J. Wareham, K.-T. Khaw and S.A. Rodwell, Baseline alcohol consumption, type of alcoholic beverage and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition-Norfolk study, Cancer Epidemiology 33 (2009), 347-354.
36. L.J. Peppone, M.C. Mahoney, K.M. Cummings, A.M. Michalek, M.E. Reid, K.B. Moysich and A. Hyland, Colorectal cancer occurs earlier in those exposed to tobacco smoke: implications for screening, Journal of Cancer Research and Clinical Oncology 134 (2008), 743-751.
37. G. Yang, W. Zheng, Y.B. Xiang, J. Gao, H.L. Li, X. Zhang, Y.T. Gao and X.O. Shu, Green tea consumption and colorectal cancer risk: A report from the Shanghai Men's Health Study, Carcinogenesis 32 (2011), 1684-1688.